Literature DB >> 1690920

Diagnostic peritoneal lavage in evaluation of acute abdominal disease.

R L Bailey1, H L Laws.   

Abstract

Diagnostic peritoneal lavage (DPL) is an established procedure in evaluation of trauma victims but is less well established for use in patients suspected of having acute intra-abdominal disease. Twenty-six seriously ill patients at our institution who had DPL for acute intra-abdominal disease form the basis of this report. Use of DPL indicated sepsis in ten patients; in seven of the ten, findings were confirmed at celiotomy or autopsy. Only one of the ten survived without laparotomy or confirmatory necropsy indicating the result of DPL had been false-positive. Sepsis was not indicated by DPL in 16 patients. Fourteen patients appeared to have true-negative results confirmed by operation (three patients), autopsy (four patients), or survival longer than two weeks (seven patients). Complications occurred in one patient whose DPL showed sepsis. Two patients with negative results of DPL died within two weeks of examination without confirmatory operation or autopsy and could not be evaluated. We therefore, consider the overall diagnostic accuracy in our patient group to be 95%. We recommend the use of DPL in patients suspected of an acute intra-abdominal disease process who are unable to undergo other evaluation for reasons such as critical illness.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690920     DOI: 10.1097/00007611-199004000-00015

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  2 in total

1.  Diagnostic value of lactate levels in acute abdomen disorders.

Authors:  Indu Verma; Satinder Kaur; Subash Goyal; Shweta Goyal; J S Multani; A P S Narang
Journal:  Indian J Clin Biochem       Date:  2013-09-26

2.  Diagnostic laparoscopy in the intensive care patient. Avoiding the nontherapeutic laparotomy.

Authors:  C P Brandt; P P Priebe; M L Eckhauser
Journal:  Surg Endosc       Date:  1993 May-Jun       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.